142 related articles for article (PubMed ID: 23602454)
1. Association of hyperglycemia mediated increased advanced glycation and erythrocyte antioxidant enzyme activity in different stages of diabetic retinopathy.
Choudhuri S; Dutta D; Chowdhury IH; Mitra B; Sen A; Mandal LK; Mukhopadhyay S; Bhattacharya B
Diabetes Res Clin Pract; 2013 Jun; 100(3):376-84. PubMed ID: 23602454
[TBL] [Abstract][Full Text] [Related]
2. Role of hyperglycemia-mediated erythrocyte redox state alteration in the development of diabetic retinopathy.
Choudhuri S; Mandal LK; Paine SK; Sen A; Dutta D; Chowdhury IH; Mukherjee A; Saha A; Bhadhuri G; Bhattacharya B
Retina; 2013 Jan; 33(1):207-16. PubMed ID: 22653543
[TBL] [Abstract][Full Text] [Related]
3. Role of N-ε- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus.
Choudhuri S; Dutta D; Sen A; Chowdhury IH; Mitra B; Mondal LK; Saha A; Bhadhuri G; Bhattacharya B
Mol Vis; 2013; 19():100-13. PubMed ID: 23378723
[TBL] [Abstract][Full Text] [Related]
4. Pentosidine and N-carboxymethyl-lysine: biomarkers for type 2 diabetic retinopathy.
Ghanem AA; Elewa A; Arafa LF
Eur J Ophthalmol; 2011; 21(1):48-54. PubMed ID: 20544678
[TBL] [Abstract][Full Text] [Related]
5. Role of Oxidative Stress and Severity of Diabetic Retinopathy in Type 1 and Type 2 Diabetes.
Bokhary K; Aljaser F; Abudawood M; Tabassum H; Bakhsh A; Alhammad S; Aleyadhi R; Almajed F; Alsubki R
Ophthalmic Res; 2021; 64(4):613-621. PubMed ID: 33498043
[TBL] [Abstract][Full Text] [Related]
6. Oxidants, antioxidants and mitochondrial function in non-proliferative diabetic retinopathy.
Rodríguez-Carrizalez AD; Castellanos-González JA; Martínez-Romero EC; Miller-Arrevillaga G; Villa-Hernández D; Hernández-Godínez PP; Ortiz GG; Pacheco-Moisés FP; Cardona-Muñoz EG; Miranda-Díaz AG
J Diabetes; 2014 Mar; 6(2):167-75. PubMed ID: 23875878
[TBL] [Abstract][Full Text] [Related]
7. Hyperlipidemia-Mediated Increased Advanced Lipoxidation End Products Formation, an Important Factor Associated with Decreased Erythrocyte Glucose-6-Phosphate Dehydrogenase Activity in Mild Nonproliferative Diabetic Retinopathy.
Choudhuri S; Roy PK; Mitra B; Sen S; Sarkar R; Das M; Biswas D; Ghosh P; Biswas A; Chakraborty S; Mondal LK
Can J Diabetes; 2017 Feb; 41(1):82-89. PubMed ID: 27916496
[TBL] [Abstract][Full Text] [Related]
8. Antioxidant enzymes and diabetic retinopathy.
Yildirim Z; Uçgun NI; Kiliç N; Gürsel E; Sepici-Dinçel A
Ann N Y Acad Sci; 2007 Apr; 1100():199-206. PubMed ID: 17460179
[TBL] [Abstract][Full Text] [Related]
9. Correlation Between Vitreous Advanced Glycation End Products, and D-dimer with Blood HbA1c Levels in Proliferative Diabetic Retinopathy.
Loho T; Venna V; Setiabudy RD; Sukartini N; Immanuel S; Kumalawati J; Victor AA; Waspadji S
Acta Med Indones; 2018 Apr; 50(2):132-137. PubMed ID: 29950532
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of vitreous levels of advanced glycation end products and angiogenic factors as biomarkers for severity of diabetic retinopathy.
Katagiri M; Shoji J; Inada N; Kato S; Kitano S; Uchigata Y
Int Ophthalmol; 2018 Apr; 38(2):607-615. PubMed ID: 28299499
[TBL] [Abstract][Full Text] [Related]
11. Delayed progression of diabetic cataractogenesis and retinopathy by Litchi chinensis in STZ-induced diabetic rats.
Kilari EK; Putta S
Cutan Ocul Toxicol; 2017 Mar; 36(1):52-59. PubMed ID: 27160797
[TBL] [Abstract][Full Text] [Related]
12. Blood antioxidant parameters in patients with diabetic retinopathy.
Siemianowicz K; Gminski J; Telega A; Wójcik A; Posielezna B; Grabowska-Bochenek R; Francuz T
Int J Mol Med; 2004 Sep; 14(3):433-7. PubMed ID: 15289896
[TBL] [Abstract][Full Text] [Related]
13. Advanced glycation index and its association with severity of diabetic retinopathy in type 2 diabetic subjects.
Anitha B; Sampathkumar R; Balasubramanyam M; Rema M
J Diabetes Complications; 2008; 22(4):261-6. PubMed ID: 18413194
[TBL] [Abstract][Full Text] [Related]
14. The evaluation of autoantibodies against oxidatively modified low-density lipoprotein (LDL), susceptibility of LDL to oxidation, serum lipids and lipid hydroperoxide levels, total antioxidant status, antioxidant enzyme activities, and endothelial dysfunction in patients with Behçet's disease.
Orem A; Yandi YE; Vanizor B; Cimşit G; Uydu HA; Malkoç M
Clin Biochem; 2002 May; 35(3):217-24. PubMed ID: 12074830
[TBL] [Abstract][Full Text] [Related]
15. Levels of selected oxidative stress markers in the vitreous and serum of diabetic retinopathy patients.
Brzović-Šarić V; Landeka I; Šarić B; Barberić M; Andrijašević L; Cerovski B; Oršolić N; Đikić D
Mol Vis; 2015; 21():649-64. PubMed ID: 26120270
[TBL] [Abstract][Full Text] [Related]
16. Soluble receptor for advanced glycation end-product (sRAGE)/pentosidine ratio: a potential risk factor determinant for type 2 diabetic retinopathy.
Ng ZX; Chua KH; Iqbal T; Kuppusamy UR
Int J Mol Sci; 2013 Apr; 14(4):7480-91. PubMed ID: 23552832
[TBL] [Abstract][Full Text] [Related]
17. Catalase/superoxide dismutase (SOD) and catalase/paraoxonase (PON) ratios may implicate poor glycemic control.
Sözmen EY; Sözmen B; Delen Y; Onat T
Arch Med Res; 2001; 32(4):283-7. PubMed ID: 11440784
[TBL] [Abstract][Full Text] [Related]
18. Modification of enzymatic antioxidants in retinal microvascular cells by glucose or advanced glycation end products.
Paget C; Lecomte M; Ruggiero D; Wiernsperger N; Lagarde M
Free Radic Biol Med; 1998 Jul; 25(1):121-9. PubMed ID: 9655530
[TBL] [Abstract][Full Text] [Related]
19. Epalrestat, an aldose reductase ihibitor, reduces the levels of Nepsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients.
Hamada Y; Nakamura J; Naruse K; Komori T; Kato K; Kasuya Y; Nagai R; Horiuchi S; Hotta N
Diabetes Care; 2000 Oct; 23(10):1539-44. PubMed ID: 11023149
[TBL] [Abstract][Full Text] [Related]
20. Relationships between vitreous levels of soluble receptor for advanced glycation end products (sRAGE) and renal function in patients with diabetic retinopathy.
Katagiri M; Shoji J; Kato S; Kitano S; Uchigata Y
Int Ophthalmol; 2017 Dec; 37(6):1247-1255. PubMed ID: 27830398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
